French-German R&D Projects Matchmaking 2025/2026

11 Aug 2025 – 11 Mar 2026 | Germany

Register
Register
Register

Rosetta Omics

Start-up

rosetta-omics.com/Paris, France
1 profile visit

About

Rosetta Omics is an innovative startup unlocking the road to precision medicine by tumor characterization via high resolution mass spectrometry profiling and AI in cancer patients.

Our mission is to help oncologists, clinicians, and pathologists to better diagnose, stratify and rank first line treatment options for cancer patients from one unique tissue slide per patient.

Rosetta Omics develops accurate predictive tests using AI to support with treatment choices for different types of cancer but also provide pharma R&D with patients molecular profile database for biomarkers validation and therapeutic targets exploration.

AREAS OF ACTIVITIES

BiotechnologyLife Sciences, Medicine & Pharmaceuticals

Representatives

Chief Scientific Officer & Co-founder

Rosetta Omics

Founder & CEO

Rosetta Omics

Marketplace (1)

  • Expertise

    AI-Enabled MultiOmics Cancer Precision Medicine Platform

    Spatial omics, proteomics mass spectrometry, gene expression analysis and advanced AI algorithms for molecular profiling and predictive test

    • Biotechnology
    • Life Sciences, Medicine & Pharmaceuticals
    Author

    Chief Scientific Officer & Co-founder at Rosetta Omics

    Paris, France